Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Nordic VS Eir raises funds for LS investing

Investors love data. So why not dig into sustainability metrics?

European Biotech Investors Cap Off Record Year in Fundraising

Tough Tech Landscape

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

AI & ML set to drive revenues in 2022

Google’s DeepMind turns first profit as revenues soar

Government to nurture AI-specializing medical scientists

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”